To view this email as a web page, click here

Today's Rundown

Featured Story

Adagio seeks IPO to bring COVID-19 antibody to market in 2022

Adagio Therapeutics has filed to raise money to bring its COVID-19 antibody to market in an initial public offering. The IPO will support phase 2/3 clinical trials that Tillman Gerngross’ Adagio is running to position ADG20 for use in the treatment and prevention of COVID-19.

read more

Top Stories

From masking to vaccines, Ad Council corrals feds, brands and media into COVID-19 campaigns

Many of the ads promoting mask-wearing, social-distancing and vaccinations during the coronavirus pandemic have had one thing in common—the Ad Council. Working with HHS, CDC and two White House administrations, along with hundreds of brands and media partners, the nonprofit marketing agency has been the COVID-19 marketing glue.

read more

Digital health dollars hit $15B high driven by telehealth investment in 2021

Global venture capital funding for digital health companies hit a $15 billion high in the first half of 2021, driven in large part by telehealth investment.

read more

COVID-19 tracker: Canada to open American border; University's vaccine mandate scores court win

Canada will allow fully vaccinated Americans into the country for nonessential travel starting Aug. 9. A federal judge has upheld Indiana University's right to require vaccinations among students this fall. And more.

read more